Pramipexole 2HCl Monohydrate is primarily used in the treatment of Parkinson's disease. It functions as a dopamine agonist, stimulating dopamine receptors in the brain to alleviate symptoms such as tremors, stiffness, and slow movement. This helps improve motor control and overall quality of life for patients. Additionally, it is prescribed for restless legs syndrome (RLS) to reduce discomfort and the urge to move the legs, particularly during periods of rest or sleep. Its effectiveness in managing these conditions makes it a valuable therapeutic option in neurology.